 |
65 Diseases |  |
5 Trials |
|
5 Trials |  |
369 News |  |
| «123456 |
- | NovoSeven (eptacog alfa) / Novo Nordisk
New P1 trial: Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State (clinicaltrials.gov) - Mar 21, 2012
P1, N=30, Completed, Sponsor: Novo Nordisk
- | NovoSeven (eptacog alfa) / Novo Nordisk
New P1 trial: Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography (clinicaltrials.gov) - Mar 21, 2012
P1, N=17, Completed, Sponsor: Novo Nordisk
- | NovoSeven (eptacog alfa) / Novo Nordisk
New P1 trial: Bioequivalence of NovoSeven (clinicaltrials.gov) - Mar 21, 2012
P1, N=28, Completed, Sponsor: Novo Nordisk
- NovoSeven (eptacog alfa) / Novo Nordisk
New P1 trial, Biopsy: Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding (clinicaltrials.gov) - Mar 20, 2012
P1, N=91, Terminated, Sponsor: Novo Nordisk
- ||| NovoSeven (eptacog alfa) / Novo Nordisk
New P1 trial: Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment (clinicaltrials.gov) - Mar 20, 2012
P1, N=127, Completed, Sponsor: Novo Nordisk
- ||| NovoSeven (eptacog alfa) / Novo Nordisk
Trial completion: Post-marketing Safety Surveillance of NovoSeven (clinicaltrials.gov) - Dec 22, 2011
P=N/A, N=194, Completed, Sponsor: Novo Nordisk
Enrolling by invitation --> Completed
- NovoSeven (eptacog alfa) / Novo Nordisk
Enrollment closed: Observational Study on Safety and Efficacy of NovoSeven (clinicaltrials.gov) - Aug 8, 2011
P=N/A, N=36, Active, not recruiting, Sponsor: Novo Nordisk
Enrolling by invitation --> Completed Enrolling by invitation --> Active, not recruiting
- warfarin / Generic mfg.
Trial termination: Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage (clinicaltrials.gov) - Aug 7, 2011
P1, N=2, Terminated, Sponsor: University of Utah
Enrolling by invitation --> Active, not recruiting Completed --> Terminated; poor enrollment
- warfarin / Generic mfg.
Enrollment change: Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage (clinicaltrials.gov) - Aug 7, 2011
P1, N=2, Terminated, Sponsor: University of Utah
Completed --> Terminated; poor enrollment N=10 --> 2